Search

everythinglearnresearchcommunity

for

Search:↓

Middle-aged and elderly men with BPH had higher hospitalization rates for COVID-19.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Higher androgen levels might make COVID-19 worse, especially in men.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Certain types of rashes in COVID-19 patients may indicate more severe illness and higher risk of death.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

A man experienced hair loss after getting COVID-19, which improved with treatment and might have been triggered by stress related to the illness.

5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

Hair loss doesn't affect COVID-19 severity.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Social media data can help track COVID-19 symptoms and predict the pandemic's status.

Lifestyle changes during the early COVID-19 outbreak led to more cases of acne and other skin conditions, but fewer cases of rosacea and skin infections.

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

The Gabrin sign may help identify COVID-19 patients at high risk who also have hair loss due to male hormones.

The study found that skin conditions in COVID-19 patients can signal serious internal organ damage and may be life-threatening.

Tailored neurorehabilitation programs improve life quality for post-COVID-19 patients.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

Many healthcare workers who had Covid-19 suffer from long-term symptoms like hair loss and fatigue, especially women.

Zinc acetate hydrate may help reduce fatigue and hair loss in post-COVID-19 patients.

Social media data can help track and predict COVID-19 symptoms and trends.

Antiandrogens might help prevent or treat COVID-19 by blocking the virus's entry into cells.

Tocilizumab might be an effective treatment for COVID-19.

People with blood group O may have a higher risk of developing post-COVID-19 syndrome.